These studies establish SGLT-2i as a cornerstone therapy for HF across the disease spectrum (61)
Update on Once-Monthly Weight Loss Drug Maritide Following Phase II Clinical Trial The Phase II trial of the once-monthly weight loss drug Maridebart cafraglutide (Amgen), also known as MariTide or AMG133, shows high discontinuation rates, largely due to gastrointestinal side effects
Mitochondria are the powerhouse of our cells and are responsible for producing energy
Mesulam MM, Guillozet A, Shaw P, Levey A, Duysen EG, Lockridge O (2002) Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine
Glycolic acid products can come in a wide range of concentrations, and its always a good idea to see a dermatologist if youre using concentrations higher than 10%, says Dr